BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising breakthroughs throughout numerous clinical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, additional trusted substitute for therapeutic use